SOLENO THERAPEUTICS INC (SLNO) Stock Income Statement
NASDAQ:SLNO - Nasdaq - US8342033094 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 210.00M | 188.00M | 41.00M | 24.40M | 31.53M | |||
| Research and Development | 77.48M | 78.57M | 25.19M | 15.27M | 21.45M | |||
| Selling, General, and Administrative Expenses | 126.00M | 106.00M | 13.00M | 9.84M | 10.81M | |||
| Operating Income | -210.00M | -188.00M | -41.00M | -24.40M | -31.53M | |||
| Interest Income/Expense | 11.71M | 11.82M | 2.58M | 300.00K | 110.00K | |||
| Other Income/Expense | N/A | 0.00 | -180.00K | 30.00K | 510.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -199.00M | -176.00M | -39.00M | -24.07M | -30.91M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -199.00M | -176.00M | -39.00M | -24.07M | -30.91M | |||
| EBITDA | -208.00M | -186.01M | -39.04M | -22.44M | -29.57M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.62 | -4.40 | -2.43 | -2.87 | -5.81 | |||
| Non GAAP EPS | -4.62 | -4.26 | -2.97 | -3.32 | -5.85 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD